Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 28.3213.968.0318.19-3.74

What is the latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 28.32 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202528.32
Mar202413.96
Mar20238.03
Mar202218.19
Mar2021-3.74

How is Core EBITDA Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 28.32
102.87
Mar2024 13.96
73.85
Mar2023 8.03
-55.85
Mar2022 18.19
Positive
Mar2021 -3.74 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹40,783.9 Cr 2.9% -2.6% 16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,341.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹160,401.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,175.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹107,100.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,715.9 Cr -4.6% -7% 1.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

2.9%

-2.6%

16.2%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses